HSK44459
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Haisco Pharmaceutical Group Co., Ltd.
Overview
HSK44459 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
HSK44459 clinical trials
Explore related
Medical disclaimer. This page summarizes research about HSK44459 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.